Published in Ann Rheum Dis on January 01, 2002
Cardiovascular co-morbidity in rheumatic diseases. Vasc Health Risk Manag (2008) 1.16
Vascular function and inflammation in rheumatoid arthritis: the role of physical activity. Open Cardiovasc Med J (2010) 0.94
Weight reduction is not a major reason for improvement in rheumatoid arthritis from lacto-vegetarian, vegan or Mediterranean diets. Nutr J (2005) 0.85
Lack of benefit of a primary care-based nurse-led education programme for people with osteoarthritis of the knee. Clin Rheumatol (2005) 0.84
Development of a Rheumatoid Arthritis Education Program using the PRECEDE_PROCEED Model. Health Promot Perspect (2011) 0.84
Results of a specific smoking cessation program for patients with arthritis in a rheumatology clinic. Rheumatol Int (2013) 0.78
Consensus statement on a framework for the management of comorbidity and extra-articular manifestations in rheumatoid arthritis. Rheumatol Int (2014) 0.77
Epidemiological evaluation quality of life in patients suffering from early rheumatoid arthritis: a pragmatic, prospective, randomized, blind allocation controlled of a modular program group intervention. Epidemiol Health (2015) 0.75
Current nutritional status of patients with rheumatic diseases in the population of Poland. Reumatologia (2015) 0.75
[Therapy of dyslipidemia in rheumatic diseases]. Z Rheumatol (2010) 0.75
How to ensure that guidelines are effective. BMJ (1995) 4.31
Sulphasalazine in rheumatoid arthritis: a double blind comparison of sulphasalazine with placebo and sodium aurothiomalate. Br Med J (Clin Res Ed) (1983) 2.63
Enteroscopic diagnosis of small bowel ulceration in patients receiving non-steroidal anti-inflammatory drugs. Lancet (1991) 2.37
Serum interleukin 6 levels in rheumatoid arthritis: correlations with clinical and laboratory indices of disease activity. Ann Rheum Dis (1993) 2.05
External fixation versus conservative treatment for distal radial fractures in adults. Cochrane Database Syst Rev (2007) 2.03
Cutting waiting lists. BMJ (1991) 2.02
Illiteracy in rheumatoid arthritis patients as determined by the Rapid Estimate of Adult Literacy in Medicine (REALM) score. Rheumatology (Oxford) (2002) 2.00
Effect of disease modifying agents on the lipid profiles of patients with rheumatoid arthritis. Ann Rheum Dis (1997) 1.87
Percutaneous pinning for treating distal radial fractures in adults. Cochrane Database Syst Rev (2007) 1.82
Does second-line therapy affect the radiological progression of rheumatoid arthritis? Ann Rheum Dis (1984) 1.69
Lack of radiological and clinical benefit over two years of low dose prednisolone for rheumatoid arthritis: results of a randomised controlled trial. Ann Rheum Dis (2004) 1.69
Impaired cell mediated immunity in haemophilia in the absence of infection with human immunodeficiency virus. Br Med J (Clin Res Ed) (1986) 1.64
Cardiovascular risk factors, including thrombotic variables, in a population with rheumatoid arthritis. Rheumatology (Oxford) (2001) 1.63
Nonsteroidal peptic damage in rheumatoid patients receiving second-line drugs. Am J Gastroenterol (1991) 1.57
Surgical interventions for treating distal radial fractures in adults. Cochrane Database Syst Rev (2003) 1.57
Sulphasalazine for rheumatoid arthritis: toxicity in 774 patients monitored for one to 11 years. Br Med J (Clin Res Ed) (1986) 1.55
Misoprostol in patients taking non-steroidal anti-inflammatory drugs. BMJ (1995) 1.54
Which component of sulphasalazine is active in rheumatoid arthritis? Br Med J (Clin Res Ed) (1985) 1.51
A rheumatological dilemma: is it possible to modify the course of rheumatoid arthritis? Can we answer the question? Ann Rheum Dis (1985) 1.50
Thiopurine methyltransferase genotype predicts therapy-limiting severe toxicity from azathioprine. Ann Intern Med (1998) 1.50
Effect of acetylator phenotype on efficacy and toxicity of sulphasalazine in rheumatoid arthritis. Ann Rheum Dis (1985) 1.49
Alteration of thiol and superoxide dismutase status in rheumatoid arthritis treated with sulphasalazine. Br J Rheumatol (1987) 1.45
Surgical interventions for treating distal radial fractures in adults. Cochrane Database Syst Rev (2001) 1.44
Small bowel ulceration in patients receiving non-steroidal anti-inflammatory drugs for rheumatoid arthritis. Q J Med (1986) 1.44
Antineutrophil cytoplasmic antibody titres in patients with recent infection. Br J Rheumatol (1993) 1.42
The 'natural' history of active rheumatoid arthritis over 3-6 months--an analysis of patients enrolled into trials of potential disease-modifying anti-rheumatic drugs, and treated with placebo. Br J Rheumatol (1993) 1.42
A case of orbital myositis associated with rheumatoid arthritis. Ann Rheum Dis (2002) 1.40
Availability of condoms in district general hospitals. BMJ (1990) 1.39
Pneumocystis carinii infection complicating cytotoxic therapy in two patients with lymphopenia, but a normal total white cell count. Br J Rheumatol (1992) 1.39
Predictive value of interleukin 1 gene polymorphisms for surgery. Ann Rheum Dis (2000) 1.38
The use of the Internet as a resource for health information among patients attending a rheumatology clinic. Rheumatology (Oxford) (2002) 1.33
Co-ordinated multidisciplinary approaches for inpatient rehabilitation of older patients with proximal femoral fractures. Cochrane Database Syst Rev (2001) 1.33
Sulphasalazine in the treatment of rheumatoid arthritis: relationship of dose and serum levels to efficacy. Br J Rheumatol (1985) 1.30
Interventions for treating proximal humeral fractures in adults. Cochrane Database Syst Rev (2003) 1.30
Sulphasalazine: a 'new' antirheumatic drug. Br J Rheumatol (1984) 1.30
Effect of sulphasalazine on the radiological progression of rheumatoid arthritis. Ann Rheum Dis (1987) 1.29
Triple therapy in early active rheumatoid arthritis: a randomized, single-blind, controlled trial comparing step-up and parallel treatment strategies. Arthritis Rheum (2008) 1.24
A double blind, randomised, multicentre comparison of two doses of intravenous iloprost in the treatment of Raynaud's phenomenon secondary to connective tissue diseases. Ann Rheum Dis (1991) 1.20
HTLV-III seropositivity in European haemophiliacs exposed to Factor VIII concentrate imported from the USA. Lancet (1984) 1.20
Clinical and laboratory studies of levamisole in patients with rheumatoid arthritis. Q J Med (1978) 1.19
Geriatric rehabilitation following fractures in older people: a systematic review. Health Technol Assess (2000) 1.18
Identification of human herpesvirus 6-specific DNA sequences in two patients with non-Hodgkin's lymphoma. Leukemia (1988) 1.18
Effects of altering dietary essential fatty acids on requirements for non-steroidal anti-inflammatory drugs in patients with rheumatoid arthritis: a double blind placebo controlled study. Ann Rheum Dis (1988) 1.16
Co-ordinated multidisciplinary approaches for inpatient rehabilitation of older patients with proximal femoral fractures. Cochrane Database Syst Rev (2000) 1.14
Continued use of non-steroidal anti-inflammatory drugs: an index of clinical efficacy. Br J Clin Pharmacol (1978) 1.14
Conservative interventions for treating distal radial fractures in adults. Cochrane Database Syst Rev (2003) 1.14
Effect of social deprivation on disease severity and outcome in patients with rheumatoid arthritis. Ann Rheum Dis (1997) 1.13
Immunological abnormalities in haemophilia: are they caused by American factor VIII concentrate? Br Med J (Clin Res Ed) (1983) 1.12
Improved functional outcome in patients with early rheumatoid arthritis treated with intramuscular gold: results of a five year prospective study. Ann Rheum Dis (1998) 1.10
Recurrent focal myositis. Rheumatology (Oxford) (1999) 1.10
Does social disadvantage contribute to the excess mortality in rheumatoid arthritis patients? Ann Rheum Dis (1999) 1.09
Does the order of second-line treatment in rheumatoid arthritis matter? Br Med J (Clin Res Ed) (1982) 1.09
Downturn in hip fracture incidence. Public Health Rep (1996) 1.09
HIV-1 infection in haemophilia. Baillieres Clin Haematol (1990) 1.09
Second line (disease modifying) treatment in rheumatoid arthritis: which drug for which patient? Ann Rheum Dis (1993) 1.08
Gold induced aplastic anaemia unresponsive to G-CSF. Ann Rheum Dis (1993) 1.08
Social surveys in HIV/AIDS: telling or writing? A comparison of interview and postal methods. Health Educ Res (1992) 1.08
Outstanding issues in use of disease-modifying agents in rheumatoid arthritis. Lancet (1999) 1.07
The relationship of sulfoxidation status to efficacy and toxicity of penicillamine in the treatment of rheumatoid arthritis. Arthritis Rheum (1990) 1.07
Physeal fractures: Part 1. Epidemiology in Olmsted County, Minnesota, 1979-1988. J Pediatr Orthop (1994) 1.06
Uptake of breast screening by Asian women. J Public Health Med (1995) 1.04
Analysis of transforming growth factor beta1 gene polymorphisms in patients with systemic sclerosis. Ann Rheum Dis (2002) 1.03
Oral gold: a comparison with placebo and with intramuscular sodium aurothiomalate. Clin Rheumatol (1984) 1.03
Disease association of two distinct interleukin-18 promoter polymorphisms in Caucasian rheumatoid arthritis patients. Genes Immun (2005) 1.02
Rehabilitation for distal radial fractures in adults. Cochrane Database Syst Rev (2006) 1.01
Pulmonary artery pressure variation in patients with connective tissue disease: 24 hour ambulatory pulmonary artery pressure monitoring. Thorax (1998) 1.00
Sex and the risk of HIV infection: the role of alcohol. Br J Addict (1992) 1.00
Audit and research. Lancet (1992) 0.99
Different methods of external fixation for treating distal radial fractures in adults. Cochrane Database Syst Rev (2008) 0.99
Oral iloprost in Raynaud's phenomenon secondary to systemic sclerosis: a multicentre, placebo-controlled, dose-comparison study. Br J Rheumatol (1998) 0.98
Can treatment really influence the radiological progression of rheumatoid arthritis? Br J Rheumatol (1986) 0.97
Increased prostacyclin metabolites and decreased red cell deformability in patients with systemic sclerosis and Raynaud's syndrome. Prostaglandins Leukot Med (1985) 0.96
Anti-inflammatory analgesic drug responders and non-responders: a clinico-pharmacological study of flurbiprofen. Br J Clin Pharmacol (1977) 0.95
Anaesthesia for treating distal radial fracture in adults. Cochrane Database Syst Rev (2002) 0.94
Does sulphoxidation state predict gold toxicity in rheumatoid arthritis? Br Med J (Clin Res Ed) (1987) 0.94
Effects of hormone replacement therapy in rheumatoid arthritis: a double blind placebo-controlled study. Ann Rheum Dis (1994) 0.92
Degree and extent of response to sulphasalazine or penicillamine therapy for rheumatoid arthritis: results from a routine clinical environment over a two-year period. Q J Med (1990) 0.92
A three year follow up of patients allocated to placebo, or oral or injectable gold therapy for rheumatoid arthritis. Ann Rheum Dis (1986) 0.92
Comparison of white blood cell dyscrasias during sulphasalazine therapy of rheumatoid arthritis and inflammatory bowel disease. Drugs (1986) 0.92
A pilot study of a Mediterranean-type diet intervention in female patients with rheumatoid arthritis living in areas of social deprivation in Glasgow. Ann Rheum Dis (2007) 0.90
Religious circumcision on the NHS: opinions of Pakistani people in Middlesbrough, England. J Epidemiol Community Health (1998) 0.90
Intention-to-treat analysis of 200 patients with rheumatoid arthritis 12 years after random allocation to either sulfasalazine or penicillamine. J Rheumatol (1998) 0.90
Antenatal screening for Down's syndrome. Lancet (1998) 0.90
Comparison of phenytoin and gold as second line drugs in rheumatoid arthritis. Ann Rheum Dis (1987) 0.90
Seatone in rheumatoid arthritis: a six-month placebo-controlled study. Ann Rheum Dis (1985) 0.90
HTLV-III antibody in sequential plasma samples: from haemophiliacs 1974-84. Lancet (1985) 0.89